节点文献

新型生物制剂在关节病型银屑病中的应用

Novel biologics in treatment of psoriatic arthritis

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 周炯郑敏

【Author】 ZHOU Jiong,ZHENG Min(Department of Dermatology,The Second Affiliated Hospital,College of Medicine,Zhejiang University,Hangzhou 310009,China)

【机构】 浙江大学医学院附属第二医院皮肤科

【摘要】 关节病型银屑病是一种与银屑病相关的炎性关节病。该疾病早期诊断困难,而且缺乏有效药物;晚期患者可出现关节强直而致残,甚至死亡。传统药物在阻止关节损害方面效果不佳,毒副作用大。新型生物制剂作为一种基于银屑病发病机制中的免疫关键步骤而研发的新药,为关节病型银屑病的治疗提供了较为有效的方案。

【Abstract】 Psoriatic arthritis is an inflammatory joint disease associated with psoriasis.Due to difficulty for early diagnosis and lack of effective therapy,the disease leads to chronic course and frequent relapse.Patients may suffer from ankylosis,disability and even death.The past treatments neither can control the disease effectively,nor be capable of inhibiting the development of structural joint damage.Based on the current psoriasis pathogenesis,novel biologics have been developed,which can aim the specific targets,resulting in more effective and safer management for psoriatic arthritis.

  • 【文献出处】 浙江大学学报(医学版) ,Journal of Zhejiang University(Medical Sciences) , 编辑部邮箱 ,2009年04期
  • 【分类号】R758.63
  • 【被引频次】9
  • 【下载频次】356
节点文献中: